Crossmark

Assessment of adherence to guidelines for biochemical monitoring and ursodeoxycholic acid treatment response in a retrospective cohort of US patients with primary biliary cholangitis

Crossref DOI link: https://doi.org/10.1136/bmjgast-2025-001899

Published Online: 2025-10-22

Published Print: 2025-10

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Gordon, Stuart C

Sahota, Amandeep

Schmidt, Mark A

Daida, Yihe G

Rupp, Loralee B

Trudeau, Sheri

Melkonian, Christina

Bowlus, Christopher L

Lu, Mei https://orcid.org/0000-0002-3313-6428
Funding

Funding for this research was provided by:

Intercept Pharmaceuticals (NA)
License Information

License valid from 2025-10-19

Document is current

Any future updates will be listed below